A Widespread Deferoxamine‐Mediated Iron‐Uptake System in Vibrio vulnificus
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Vibrio vulnificus can use the standard iron chelator deferoxamine (Desferal) for efficient iron-uptake via the specific receptor DesA, which is encoded by desA. We investigated the ubiquity of the deferoxamine-mediated iron-uptake system in V. vulnificus strains and the potential risk of the system. By polymerase chain reaction (PCR), desA was found in 10 of 10 clinical strains and in 9 of 10 environmental strains, and their growth was stimulated by deferoxamine. By reverse-transcriptase PCR, desA was expressed only under iron-limited conditions containing deferoxamine. V. vulnificus growth in the presence of deferoxamine was suppressed by desA mutation, and the suppressed growth was recovered by desA complementation. Deferoxamine stimulated V. vulnificus growth in iron-limited in vitro and ex vivo backgrounds containing transferrin-bound iron. Overall, V. vulnificus can use transferrin-bound iron via the widespread deferoxamine-mediated iron-uptake system; this cautions that deferoxamine therapy in patients with iron overload may increase the risk of fatal infections caused by V. vulnificus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chelation therapy with desferrioxamine may therefore increase the risk of infection in patients with iron overload (Kim et al., 2007).”
From Iron in infection and immunity (2013) · cites this paper as Kim et al., 2007
In the citing paper
“For example, V. vulnificus, S. aureus, and Y. enterocolitica, among others, can utilize desferrioxamine B as an iron source.”
From Iron in infection and immunity (2013) · cites this paper as Kim et al., 2007
Citations
Cites
Ferrozine---a new spectrophotometric reagent for iron
Stookey, L. L. (1970) · Analytical Chemistry · doi:10.1021/ac60289a016 · Cited by 4,661
Ditta, G., Stanfield, S., Corbin, D., & Helinski, D. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7347 · Cited by 2,667
Miller, V. L., & Mekalanos, J. J. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.6.2575-2583.1988 · Cited by 2,126
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-3-486_3 · Cited by 2,056
Herrero, M., de Lorenzo, V, & Timmis, K. N. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.11.6557-6567.1990 · Cited by 1,586
de Lorenzo, V, Herrero, M., Jakubzik, U., & Timmis, K. N. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.11.6568-6572.1990 · Cited by 1,444
Iron-Chelating Therapy and the Treatment of Thalassemia
Olivieri, N. F., & Brittenham, G. M. (1997) · Blood · doi:10.1182/blood.v89.3.739 · Cited by 1,089
Staskawicz, B., Dahlbeck, D., Keen, N., & Napoli, C. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.12.5789-5794.1987 · Cited by 851
Role of iron in the pathogenesis of Vibrio vulnificus infections
Wright, A. C., Simpson, L. M., & Oliver, J. D. (1981) · Infection and Immunity · doi:10.1128/iai.34.2.503-507.1981 · Cited by 343
Iron and immunity: a double-edged sword.
Weiss, G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1070.x · Cited by 317
Falkow, S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro799 · Cited by 293
Iron and infection: the heart of the matter
Bullen, J. J., Rogers, H. J., Spalding, P. B., & Ward, C. G. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.11.010 · Cited by 273
Iron-withholding strategy in innate immunity
Ong, S. T., Shan Ho, J. Z., Ho, B., & Ding, J. L. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.02.004 · Cited by 269
(2005) · PubMed · Cited by 246
The detection of four molecular forms of human transferrin during the iron binding process
Makey, D. G., & Seal, U. S. (1976) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(76)90270-1 · Cited by 232
Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients
Hoffbrand, A. V., AL-Refaie, F., Davis, B., Siritanakatkul, N., Jackson, B. F. A., Cochrane, J., Prescott, E., & Wonke, B. (1998) · Blood · doi:10.1182/blood.v91.1.295 · Cited by 205
Hemochromatosis, Iron, and Septicemia Caused by Vibrio vulnificus
Bullen, J. J. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400080096018 · Cited by 190
Siderophore production by Vibrio vulnificus
Simpson, L. M., & Oliver, J. D. (1983) · Infection and Immunity · doi:10.1128/iai.41.2.644-649.1983 · Cited by 167
Role of catechol siderophore synthesis in Vibrio vulnificus virulence
Litwin, C. M., Rayback, T. W., & Skinner, J. (1996) · Infection and Immunity · doi:10.1128/iai.64.7.2834-2838.1996 · Cited by 165
Brown, J. S., Ogunniyi, A. D., Woodrow, M. C., Holden, D. W., & Paton, J. C. (2001) · Infection and Immunity · doi:10.1128/iai.69.11.6702-6706.2001 · Cited by 164
Sebulsky, M. T., Hohnstein, D., Hunter, M. D., & Heinrichs, D. E. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.16.4394-4400.2000 · Cited by 145
Vibrio vulnificus septicemia in Korea: Clinical and epidemiologic findings in seventy patients
Park, S. D., Shon, H. S., & Joh, N. J. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70059-b · Cited by 140
Identification and characterization of additional flagellin genes from Vibrio anguillarum
McGee, K., Hörstedt, P., & Milton, D. L. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.17.5188-5198.1996 · Cited by 138
Iron: Mammalian defense systems, mechanisms of disease, and chelation therapy approaches
Kontoghiorghes, G. J., & Weinberg, E. D. (1995) · Blood Reviews · doi:10.1016/0268-960x(95)90038-1 · Cited by 134
Iron and infection: competition between host and microbes for a precious element
MARX, J. (2002) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2002.0001 · Cited by 129
Functional defects in phagocytic cells from patients with iron overload
van Asbeck, B. S., Marx, J. J. M., Struyvenberg, A., & Verhoef, J. (1984) · Journal of Infection · doi:10.1016/s0163-4453(84)93955-0 · Cited by 111
Litwin, C. M., & Byrne, B. L. (1998) · Infection and Immunity · doi:10.1128/iai.66.7.3134-3141.1998 · Cited by 110
Brett, P. J., & Woods, D. E. (1996) · Infection and Immunity · doi:10.1128/iai.64.7.2824-2828.1996 · Cited by 104
Starks, A. M., Schoeb, T. R., Tamplin, M. L., Parveen, S., Doyle, T. J., Bomeisl, P. E., Escudero, G. M., & Gulig, P. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5785-5793.2000 · Cited by 101
Webster, A. C. D., & Litwin, C. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.2.526-534.2000 · Cited by 90
Siderophore production by phytopathogenic microbial species
Leong, S. A., & Neilands, J. B. (1982) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(82)90356-3 · Cited by 84
Brennt, C. E., Wright, A. C., Dutta, S. K., & Morris, J. G. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.5.1030 · Cited by 81
Berner, I., Konetschny-Rapp, S., Jung, G., & Winkelmann, G. (1988) · BioMetals · doi:10.1007/bf01128017 · Cited by 71
Lesic, B., Foulon, J., & Carniel, E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1741-1745.2002 · Cited by 65
van Asbeck, B. S., Marcelis, J. H., Marx, J. J. M., Struyvenberg, A., van Kats-Renaud, J. H., & Verhoef, J. (1983) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02013899 · Cited by 64
Isolation and identification of ferrioxamine G and E inHafnia alvei
Reissbrodt, R., Rabsch, W., Chapeaurouge, A. D., Jung, G., & Winkelmann, G. (1990) · BioMetals · doi:10.1007/bf01141179 · Cited by 56
Regulation system for protease production inVibrio vulnificus
Kawase, T., Miyoshi, S.-I., Sultan, Z., & Shinoda, S. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.09.023 · Cited by 52
Ferrophilic Characteristics of Vibrio vulnificus and Potential Usefulness of Iron Chelation Therapy
Kim, C., Park, R., Choi, M., Sun, H., & Shin, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/509822 · Cited by 46
Self-citationTanabe, T., Naka, A., Aso, H., Nakao, H., Narimatsu, S., Inoue, Y., Ono, T., & Yamamoto, S. (2005) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2005.tb03671.x · Cited by 44
van Asbeck, B. S., Marcelis, J. H., van Kats-Renaud, J. H., Jaarsma, E. Y., & Verhoef, J. (1983) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02013900 · Cited by 42
Kim, C.-M., Park, R.-Y., Park, J.-H., Sun, H.-Y., Bai, Y.-H., Ryu, P.-Y., Kim, S.-Y., Rhee, J.-H., & Shin, S.-H. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.911 · Cited by 40
Self-citationTanabe, T., Takata, N., Naka, A., Moon, Y., Nakao, H., Inoue, Y., Narimatsu, S., & Yamamoto, S. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.06.025 · Cited by 32
Aso, H., Miyoshi, S.-I., Nakao, H., Okamoto, K., & Yamamoto, S. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11246.x · Cited by 32
Production of Catechol-Siderophore and Utilization of Transferrin-Bound Iron in Bacillus cereus
Park, R., Choi, M.-H., Sun, H., & Shin, S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1132 · Cited by 31
Self-citationVibrio vulnificus metalloprotease VvpE has no direct effect on iron-uptake from human hemoglobin.
Sun, H., Han, S.-I., Choi, M., Kim, S., Kim, C., & Shin, S. (2006) · PubMed · Cited by 24
Self-citationShin, S., Sun, H., Park, R., Kim, C., Kim, S.-Y., & Rhee, J.-H. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.05.015 · Cited by 17
Self-citationChoi, M., Park, R., Sun, H., Kim, C., Bai, Y.-H., Lee, S.-E., Kim, S., Kim, Y., Rhee, J.-H., & Shin, S. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00086.x · Cited by 10
Self-citation
Research works printed but not linked: 4
- Gulig PA, 2005, J Microbiol, 43, 118
- Kushner JP, 1988, Philadelphia: WB Saunders, 892
- Sun HY, 2006, J Microbiol, 44, 537
- Makey DG, 1976, Biochem Biophys Acta, 453, 250
Cited by
Iron in infection and immunity
Cassat, J. E., & Skaar, E. P. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.04.010 · Cited by 1,214
Vibrio vulnificus: Disease and Pathogenesis
Jones, M. K., & Oliver, J. D. (2009) · Infection and Immunity · doi:10.1128/iai.01046-08 · Cited by 720
“vulnificus can take up iron independently of vulnibactin (59).”
BackgroundHorseman, M. A., & Surani, S. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.11.003 · Cited by 343
Vibrio Iron Transport: Evolutionary Adaptation to Life in Multiple Environments
Payne, S. M., Mey, A. R., & Wyckoff, E. E. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00046-15 · Cited by 121
A Chimeric Siderophore Halts Swarming Vibrio
Böttcher, T., & Clardy, J. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310729 · Cited by 60
Metadata
- Authors
- Kim, C., Park, Y., & Shin, S.
- Affiliations
- Chosun University (KR)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-15
- Volume
- 196
- Issue
- 10
- Pages
- 1537-1545
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W1952713633
- Cited by
- 49
- References
- 47
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 4
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Vibrio bacteria research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- Vibrio vulnificus, deferoxamine, iron absorption, iron limitation, transferrin-bound iron, iron chelators, iron overload, bacterial virulence
- MeSH terms
- Bacterial Proteins, Deferoxamine, DNA, Bacterial, Humans, Iron Chelating Agents, Repressor Proteins, RNA, Bacterial, Gene Expression Regulation, Bacterial, Polymerase Chain Reaction, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Vibrio vulnificus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.